Alpha Cognition Inc. (OTC:ACOGF) Forecasted to Post FY2023 Earnings of ($0.09) Per Share

Alpha Cognition Inc. (OTC:ACOGFGet Rating) – Investment analysts at Zacks Small Cap raised their FY2023 earnings estimates for Alpha Cognition in a research report issued on Wednesday, March 15th. Zacks Small Cap analyst J. Vandermosten now expects that the company will earn ($0.09) per share for the year, up from their prior forecast of ($0.17). The consensus estimate for Alpha Cognition’s current full-year earnings is ($0.09) per share.

Separately, Raymond James downgraded shares of Alpha Cognition from an “outperform” rating to a “market perform” rating in a research report on Friday, February 10th.

Alpha Cognition Trading Down 12.8 %

ACOGF opened at C$0.30 on Friday. Alpha Cognition has a 1-year low of C$0.15 and a 1-year high of C$1.08. The company has a market capitalization of C$18.30 million, a PE ratio of -1.67 and a beta of 2.92. The firm’s 50 day simple moving average is C$0.27 and its two-hundred day simple moving average is C$0.30.

Alpha Cognition Company Profile

(Get Rating)

Alpha Cognition Inc, a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; and ALPHA-0602, a gene therapy for the treatment of ALS.

Further Reading

Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with's FREE daily email newsletter.